Cite
MLA Citation
Yoshiya Tanaka et al.. “Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea.” RMD open, vol. 7, no. 2, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100133911530.0x000005